Attivare Therapeutics, Inc. — Form D/A
Attivare Therapeutics, Inc. of NATICK, MA, a company, filed a Form D amendment with the SEC on 2021-12-17. The offering totals $7.8M, of which $5.9M was reported sold. Industry: Other.
Offering
- Filed: 2021-12-17
- Form: D/A
- Accession: 0001880794-21-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $7.8M
- Amount sold: $5.9M
- Remaining: $2.0M
- Investors: 23
- Date of first sale: 2021-08-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-412051
Issuer
- Name: Attivare Therapeutics, Inc.
- CIK: 0001880794
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 22 STRATHMORE ROAD, NATICK, MA, 01760
- Phone: 857-675-1592
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jessica McDonough | Director | Natick, MA |
| Zeshan Muhammedi | Director | Claymont, DE |
| Joaquim Trias | Director | Natick, MA |
| Edward Doherty | Executive Officer | Natick, MA |
| Joaquim Trias | Executive Officer | Natick, MA |
| Edward Doherty | Director | Natick, MA |
Other filings by this issuer (1)
More